{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:40:39Z","timestamp":1784011239098,"version":"3.55.0"},"reference-count":24,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,2]]},"abstract":"<jats:p>We retrospectively analyzed the background, clinical features, and treatment response of 50 cases of imported loiasis who presented between 2000 and 2014 to the Hospital for Tropical Diseases (HTD), London, United Kingdom. Of them, 29 were migrants from, and 21 were visitors to, countries where the disease is endemic. Clinical features differed between these groups. Migrants experienced fewer Calabar swellings (odds ratio [OR] = 0.12), more eye worm (OR = 3.4), more microfilaremia (OR = 3.5), lower filarial antibody levels, and lower eosinophil counts (<jats:italic>P<\/jats:italic> &lt; 0.05 for all tests). Among 46 patients who were started on treatment at HTD, 33 (72%) received diethylcarbamazine (DEC) monotherapy as first-line treatment, and among 26 patients who were followed up after treatment, seven (27%) needed a second course of treatment. There were 46 courses of treatment with DEC, and 20 (43%) of them had reactions. All patients with microfilaremia &gt; 3,000 microfilariae\/mL and all those with an elevated C-reactive protein (CRP) (\u2265 5 mg\/L) before treatment had reactions (<jats:italic>P<\/jats:italic> = 0.10 and <jats:italic>P<\/jats:italic> = 0.01, respectively). These data suggest that monotherapy with DEC may not be the optimal treatment for patients with loiasis, particularly for those with a high microfilarial load.<\/jats:p>","DOI":"10.4269\/ajtmh.15-0214","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T02:00:42Z","timestamp":1435024842000},"page":"607-611","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London"],"prefix":"10.4269","volume":"93","author":[{"given":"Makoto","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Boadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"ref1","series-title":"PLoS Negl Trop Dis","first-page":"e1210","article-title":"The geographic distribution of Loa loa in Africa: results of large-scale implementation of the rapid assessment procedure for loiasis (RAPLOA)","volume":"5","author":"Zoure","year":"2011"},{"key":"ref2","series-title":"Lancet Infect Dis","first-page":"353","article-title":"Loa loa\u2014does it deserve to be neglected?","volume":"14","author":"Metzger","year":"2014"},{"key":"ref3","series-title":"Ann Trop Med Parasitol","first-page":"715","article-title":"Loiasis","volume":"100","author":"Boussinesq","year":"2006"},{"key":"ref4","series-title":"PLoS Negl Trop Dis","first-page":"e88","article-title":"Filariasis in travelers presenting to the GeoSentinel Surveillance Network","volume":"1","author":"Lipner","year":"2007"},{"key":"ref5","series-title":"J Infect","first-page":"103","article-title":"Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the UK","volume":"33","author":"Churchill","year":"1996"},{"key":"ref6","series-title":"Travel Med Infect Dis","first-page":"366","article-title":"Imported loiasis in France: a retrospective analysis of 47 cases","volume":"11","author":"Gantois","year":"2013"},{"key":"ref7","series-title":"J Infect Dis","first-page":"1318","article-title":"Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation","volume":"163","author":"Klion","year":"1991"},{"key":"ref8","series-title":"Travel Med Infect Dis","first-page":"713","article-title":"Imported loiasis in Italy: an analysis of 100 cases","volume":"12","author":"Gobbi","year":"2014"},{"key":"ref9","series-title":"J Infect Dis","first-page":"544","article-title":"Immunologic correlates of the hyperresponsive syndrome of loiasis","volume":"157","author":"Nutman","year":"1988"},{"key":"ref10","series-title":"Trop Med Parasitol","first-page":"287","article-title":"Current knowledge on the epidemiology, diagnosis, immunology, and treatment of loiasis","volume":"46","author":"Wahl","year":"1995"},{"key":"ref11","series-title":"Lancet","first-page":"18","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997"},{"key":"ref12","series-title":"Am J Trop Med Hyg","first-page":"684","article-title":"Five cases of encephalitis during treatment of loiasis with diethylcarbamazine","volume":"44","author":"Carme","year":"1991"},{"key":"ref13","series-title":"Trans R Soc Trop Med Hyg","first-page":"983","article-title":"Loiasis: African eye worm","volume":"102","author":"Padgett","year":"2008"},{"key":"ref14","series-title":"J Travel Med","first-page":"140","article-title":"Loiasis: new epidemiologic insights and proposed treatment strategy","volume":"19","author":"Boussinesq","year":"2012"},{"key":"ref15","series-title":"Ann Trop Med Parasitol","first-page":"151","article-title":"Loiasis\u2014a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon","volume":"101","author":"Takougang","year":"2007"},{"key":"ref16","series-title":"J Travel Med","first-page":"50","article-title":"The African eye worm: a case report and review","volume":"15","author":"Ali","year":"2008"},{"key":"ref17","series-title":"J Infect Dis","first-page":"10","article-title":"Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations","volume":"154","author":"Nutman","year":"1986"},{"key":"ref18","series-title":"J Infect Dis","first-page":"604","article-title":"Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up","volume":"169","author":"Klion","year":"1994"},{"key":"ref19","series-title":"Int J Infect Dis","first-page":"e649","article-title":"Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years","volume":"16","author":"Antinori","year":"2012"},{"key":"ref20","series-title":"J Travel Med","first-page":"186","article-title":"Loiasis with pleural and peritoneal involvement","volume":"19","author":"Ghys","year":"2012"},{"key":"ref21","series-title":"Am J Trop Med Hyg","first-page":"461","article-title":"Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis","volume":"58","author":"Boussinesq","year":"1998"},{"key":"ref22","series-title":"Filaria J","first-page":"S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003"},{"key":"ref23","series-title":"Trans R Soc Trop Med Hyg","first-page":"777","article-title":"Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg\/kg) versus current standard dose (150 microg\/kg)","volume":"101","author":"Kamgno","year":"2007"},{"key":"ref24","series-title":"Filaria J","first-page":"S4","article-title":"Clinical picture, epidemiology, and outcome of Loa-associated adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/93\/3\/article-p607.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/93\/3\/article-p607.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/93\/3\/article-p607.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:04:40Z","timestamp":1723057480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/93\/3\/article-p607.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":24,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.15-0214","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}